- Home
- TITN vs TRVI Comparison
TITN vs TRVI Comparison
Compare TITN & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TITN
- TRVI
- Stock Information
- Founded
- TITN 1980
- TRVI 2011
- Country
- TITN United States
- TRVI United States
- Employees
- TITN N/A
- TRVI N/A
- Industry
- TITN Other Specialty Stores
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- TITN Consumer Discretionary
- TRVI Health Care
- Exchange
- TITN Nasdaq
- TRVI Nasdaq
- Market Cap
- TITN 341.6M
- TRVI 363.7M
- IPO Year
- TITN 2007
- TRVI 2019
- Fundamental
- Price
- TITN $18.14
- TRVI $4.60
- Analyst Decision
- TITN Buy
- TRVI Strong Buy
- Analyst Count
- TITN 5
- TRVI 8
- Target Price
- TITN $19.20
- TRVI $9.31
- AVG Volume (30 Days)
- TITN 427.0K
- TRVI 739.7K
- Earning Date
- TITN 03-20-2025
- TRVI 03-19-2025
- Dividend Yield
- TITN N/A
- TRVI N/A
- EPS Growth
- TITN N/A
- TRVI N/A
- EPS
- TITN 1.34
- TRVI N/A
- Revenue
- TITN $2,794,333,000.00
- TRVI N/A
- Revenue This Year
- TITN N/A
- TRVI N/A
- Revenue Next Year
- TITN N/A
- TRVI N/A
- P/E Ratio
- TITN $13.50
- TRVI N/A
- Revenue Growth
- TITN 12.25
- TRVI N/A
- 52 Week Low
- TITN $12.30
- TRVI $2.30
- 52 Week High
- TITN $27.13
- TRVI $5.05
- Technical
- Relative Strength Index (RSI)
- TITN 53.71
- TRVI 62.80
- Support Level
- TITN $17.91
- TRVI $3.93
- Resistance Level
- TITN $19.81
- TRVI $4.14
- Average True Range (ATR)
- TITN 0.84
- TRVI 0.29
- MACD
- TITN -0.14
- TRVI 0.06
- Stochastic Oscillator
- TITN 32.93
- TRVI 64.82
About TITN Titan Machinery Inc.
Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.